Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.51 CAD
9.38 M CAD
23.80 M CAD
10.51 M
About CONAVI MED CORPORATION
Sector
Industry
CEO
Thomas Looby
Website
Headquarters
Toronto
FIGI
BBG000Q2MYQ9
Conavi Medical Corp. engages in the designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. Its patented Novasight Hybrid™ System is the first system to combine both intravascular ultrasound and optical coherence tomography to enable simultaneous and co-registered imaging of coronary arteries. The company is headquartered in Toronto, Canada.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of CNVI is 0.93 CAD — it has increased by 5.56% in the past 24 hours. Watch CONAVI MED CORPORATION stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSXV exchange CONAVI MED CORPORATION stocks are traded under the ticker CNVI.
CNVI stock has fallen by −16.67% compared to the previous week, the month change is a −15.56% fall, over the last year CONAVI MED CORPORATION has showed a −66.18% decrease.
CNVI reached its all-time high on Apr 7, 2014 with the price of 2,072.07 CAD, and its all-time low was 1.01 CAD and was reached on Nov 8, 2024. View more price dynamics on CNVI chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
CNVI stock is 6.45% volatile and has beta coefficient of 1.06. Track CONAVI MED CORPORATION stock price on the chart and check out the list of the most volatile stocks — is CONAVI MED CORPORATION there?
Today CONAVI MED CORPORATION has the market capitalization of 15.32 M, it has decreased by −8.18% over the last week.
Yes, you can track CONAVI MED CORPORATION financials in yearly and quarterly reports right on TradingView.
CONAVI MED CORPORATION is going to release the next earnings report on Nov 12, 2024. Keep track of upcoming events with our Earnings Calendar.
CNVI net income for the last quarter is −1.46 M CAD, while the quarter before that showed −1.09 M CAD of net income which accounts for −33.90% change. Track more CONAVI MED CORPORATION financial stats to get the full picture.
No, CNVI doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 12, 2024, the company has 16.00 employees. See our rating of the largest employees — is CONAVI MED CORPORATION on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CONAVI MED CORPORATION EBITDA is −2.96 M CAD, and current EBITDA margin is 58.48%. See more stats in CONAVI MED CORPORATION financial statements.
Like other stocks, CNVI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CONAVI MED CORPORATION stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CONAVI MED CORPORATION technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CONAVI MED CORPORATION stock shows the strong sell signal. See more of CONAVI MED CORPORATION technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.